Charlie Starnes
- Oncology top 5%
- Immunology top 10%
- Molecular Biology
- Biotechnology top 5%
- Pulmonary and Respiratory Medicine
- Co-authors
- B WiemannSheila ScullySean MoronyColin R. DunstanCasey CapparelliPaul J. KostenuikBrian VarnumJennifer McNinch
- Topics
- Bone health and treatments (4 papers)Cancer, Hypoxia, and Metabolism (4 papers)Bone health and osteoporosis research (3 papers)
- Cited by
- OncologyImmunologyBiotechnology
- Partner nations
- United StatesCanada
In The Last Decade
Charlie Starnes
16 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Oncology 567
- Immunology 407
- Molecular Biology 388
- Biotechnology 110
- Pulmonary and Respiratory Medicine 108
Countries citing papers authored by Charlie Starnes
This map shows the geographic impact of Charlie Starnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlie Starnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlie Starnes more than expected).
Fields of papers citing papers by Charlie Starnes
This network shows the impact of papers produced by Charlie Starnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlie Starnes. The network helps show where Charlie Starnes may publish in the future.
Co-authorship network of co-authors of Charlie Starnes
This figure shows the co-authorship network connecting the top 25 collaborators of Charlie Starnes. A scholar is included among the top collaborators of Charlie Starnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlie Starnes. Charlie Starnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 24 | |
| 3 | 19 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 26 | |
| 7 | 3 | |
| 8 | AMG 706 induces the rapid destruction of tumor microvessels in nude mice | 2 |
| 9 | 7 | |
| 10 | 82 | |
| 11 | The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy | 11 |
| 12 | 5 | |
| 13 | Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. | 122 |
| 14 | 202 | |
| 15 | 342 | |
| 16 | 198 |
About Charlie Starnes
Charlie Starnes is a scholar working on Orthopedics and Sports Medicine, Cancer Research and Oncology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Bone health and osteoporosis research (3 papers). The work is most often cited by research in Oncology (567 citations), Immunology (407 citations) and Biotechnology (110 citations). Charlie Starnes has collaborated with scholars based in United States and Canada. Frequent co-authors include B Wiemann, Sheila Scully, Sean Morony, Colin R. Dunstan, Casey Capparelli, Paul J. Kostenuik, Brian Varnum, Jennifer McNinch, Christine L. Shaklee and Thomas C. Boone. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.